Efficacy of Trigger Points Massage in Severity of Chronic Tension Headache:An Unmasked, Randomized, Controlled Trial
Trial Snapshot
- Phase
- Not Applicable
- Status
- Completed
- Enrollment
- 80
- Primary Endpoint
- Headache severity change
Study Overview
Brief Summary
Patients with IHS criteria of chronic tension headache , considering inclusion and exclusion criteria, enrolled to this study. They will be randomized to intervention or control group by block randomization method, then treat by standard drug( nortriptyline 10 mg daily) or trigger point massage.
They report severity, frequency, duration of headaches and number of analgesic drugs in diary during week 1 and week 4. Then data based on dairy will be analysis.
Study Design
- Study Type
- Interventional
- Allocation
- Randomized
- Intervention Model
- Parallel
- Primary Purpose
- Treatment
- Masking
- None
Eligibility Criteria
- Ages
- 18 Years to 60 Years (Adult)
- Sex
- All
- Accepts Healthy Volunteers
- Yes
Inclusion Criteria
- •Chronic tension type headache according to IHS criteria
- •Finding painful trigger point in physical examination
- •no contraindication for massage
- •no prophylactic treatment
- •written inform consent
Exclusion Criteria
- •Dementia or severe cognitive impairment
- •Under Treatment with drugs with prophylactic effect
- •History of RA or Cervicocephalic fracture or other skeletal deformity
- •Other complementary treatment
Arms & Interventions
Intervention
Trigger point massage
Intervention: Massage (Other)
Control
Treatment with standard drug Nortriptyline
Intervention: Massage (Other)
Outcomes
Primary Outcomes
Headache severity change
Time Frame: Mean Visual Analogue Scale sore change in week 4 from the baseline
By Visual Analogue Scale score,from 0 that indicate no pain to 10 that indicate severe pain
Secondary Outcomes
- Headache duration change(Change in Time duration in week 4 from the baseline)
- Headache frequency change(Change in number of attacks in week 4 from the base line)
- Number of analgesic change(Change in Number of analgesic drugs used in week 4 from the baseline)
Investigators
Athena Sharifi Razavi
Assistant Professor in Neurology
Mazandaran University of Medical Sciences